- Investigator
- Kethandapatti Balaji
- Ages
- 18 Years - 99 Years
- Sexes
- All
Clinical trials
-
BCG in combination with durvalumab in adult BCG-naive, high-risk NMIBC participants -
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD patients in the home 鈥� a multi-center randomized controlled trial - Investigator
- Mehdi S Mirsaeidi
- Ages
- 30 Years - NA Years
- Sexes
- All
-
Central Nervous System Derived Exosomes: A Novel Source of Biomarkers for Neonatal Hypoxic Ischemic Encephalopathy - Investigator
- Mark Hudak
- Ages
- 0 Years - 1 Years
- Sexes
- All
-
A Phase 1 Study of EG-70 as an Intravesical Administration to Patients with BCG -Unresponsive NMIBC - Investigator
- Mark G Bandyk
- Ages
- 18 Years - 101 Years
- Sexes
- All
-
A Study of the Efficacy and Safety of Treatment With MNKD-101 When Added to GBT in Participants with Pulmonary Nontuberculous Mycobacterial Infection - Investigator
- Mehdi S Mirsaeidi
- Ages
- 18 Years - 85 Years
- Sexes
- All
-
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults with Cutaneous Sarcoidosis - Investigator
- Mehdi S Mirsaeidi
- Ages
- 18 Years - 75 Years
- Sexes
- All
-
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis (20210052) - Investigator
- Vandana K Seeram
- Ages
- 40 Years - 99 Years
- Sexes
- All
-
A Phase 1/2 Study of EG-70 as an Intravesical Administration to Patients with BCG-Unresponsive NMIBC and High-Risk NMIBC who are BCG Na茂ve/Received Incomplete BCG Treatment - Investigator
- Kethandapatti Balaji
- Ages
- 18 Years - 100 Years
- Sexes
- All
-
The American Lung Association (ALA) Lung Health Cohort (LHC) - Investigator
- Vandana K Seeram
- Ages
- 25 Years - 35 Years
- Sexes
- All